Structural Requirements Of Histone Deacetylase Inhibitors: SAHA Analogs Modified On The Hydroxamic Acid.
Anton V. Bieliauskas, Sujith V. W. Weerasinghe, Ahmed T Negmeldin, Mary Kay H Pflum
Published 2016 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
Histone deacetylase (HDAC) proteins have emerged as targets for anti-cancer therapeutics, with several inhibitors used in the clinic, including suberoylanilide hydroxamic acid (SAHA, vorinostat). Because SAHA and many other inhibitors target all or most of the 11 human HDAC proteins, the creation of selective inhibitors has been studied intensely. Recently, inhibitors selective for HDAC1 and HDAC2 were reported where selectivity was attributed to interactions between substituents on the metal binding moiety of the inhibitor and residues in the 14-Å internal cavity of the HDAC enzyme structure. Based on this earlier work, we synthesized and tested SAHA analogs with substituents on the hydroxamic acid metal binding moiety. The N-substituted SAHA analogs displayed reduced potency and solubility, but greater selectivity, compared to SAHA. Docking studies suggested that the N-substituent accesses the 14-Å internal cavity to impart preferential inhibition of HDAC1. These studies with N-substituted SAHA analogs are consistent with the strategy exploiting the 14-Å internal cavity of HDAC proteins to create HDAC1/2 selective inhibitors.
This paper references
Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors.
Giuseppe Giannini (2009)
Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid.
Anton V. Bieliauskas (2007)
A NEW FACILE AND EXPEDITIOUS SYNTHESIS OF N-HYDROXY-N′-PHENYLOCTANEDIAMJDE, A POTENT INDUCER OF TERMINAL CYTODIFFERECNTIATION
Antonello Mai (2001)
Alkylation of n-benzyloxyureas and carbamates
Richard B. Sulsky (1989)
Mutagenesis Studies of the 14 Å Internal Cavity of Histone Deacetylase 1: Insights toward the Acetate-Escape Hypothesis and Selective Inhibitor Design
Magdalene Kamanthe Wambua (2014)
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).
Joey L Methot (2008)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Nagma Khan (2008)
Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
Di-Fei Wang (2005)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Saverio Minucci (2006)
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
Alessandro Vannini (2004)
Python: a programming language for software integration and development.
Michel F. Sanner (1999)
Structural basis for the design and synthesis of selective HDAC inhibitors.
Simone Di Micco (2013)
25 years after the nucleosome model: chromatin modifications.
Jishan Wu (2000)
Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity*
Anja Schuetz (2008)
o-Iodoxybenzoic acid (IBX) as a viable reagent in the manipulation of nitrogen- and sulfur-containing substrates: scope, generality, and mechanism of IBX-mediated amine oxidations and dithiane deprotections.
Kyriacos C Nicolaou (2004)
The structural requirements of histone deacetylase inhibitors: suberoylanilide hydroxamic acid analogs modified at the C6 position.
Sun Ea Choi (2012)
Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain*
Matthew J Bottomley (2008)
On the function of the internal cavity of histone deacetylase protein 8: R37 is a crucial residue for catalysis.
Shozeb M. Haider (2011)
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.
Oscar Miguel Moradei (2007)
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
Antonello Mai (2005)
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides.
Jerome C Bressi (2010)
Isoform-selective histone deacetylase inhibitors.
Anton V. Bieliauskas (2008)
Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?
Tom C. Karagiannis (2007)
Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates
Christopher J Millard (2013)
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.
John R. Somoza (2004)
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.
Guillermina L Estiú (2008)
Isoform-specific histone deacetylase inhibitors: the next step?
Sriram Balasubramanian (2009)
On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors.
Di-Fei Wang (2004)
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Michael S. Finnin (1999)
Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2).
David J Witter (2008)
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.
Ivan V. Gregoretti (2004)
Structure of HDAC3 bound to corepressor and inositol tetraphosphate
Peter J. Watson (2012)
HDAC inhibitors overcome first hurdle
Ken Garber (2007)
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Garrett M. Morris (2009)
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.
Sun Ea Choi (2011)
Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids.
Marc Lamblin (2010)
This paper is referenced by
Design, Synthesis And Biological Evaluation Of Histone Deacetylase (hdac) Inhibitors: Saha (vorinostat) Analogs And Biaryl Indolyl Benzamide Inhibitors Display Isoform Selectivity
Ahmed T Negmeldin (2017)
Development of a UV-Cleavable Protecting Group for Hydroxylamines, Synthesis of a StructurallyWide Variety of Hydroxamic Acids, and Identification of Histone Deacetylase Inhibitors
Kim T. Mortensen (2017)
The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
Ahmed T Negmeldin (2017)
OleD Loki as a catalyst for hydroxamate glycosylation.
Ryan T Hughes (2019)
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies.
Margherita Brindisi (2018)
Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity.
Ahmed T Negmeldin (2017)